# Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data

> **NCT04736693** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 18028 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Raloxifene
- **DRUG:** Zoledronic Acid

## Key facts

- **NCT ID:** NCT04736693
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2021-02-18
- **Final completion:** 2021-02-18
- **Target enrollment:** 18028 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04736693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04736693, "Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04736693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*